Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.96 |
| ▸ | PARP1 | P09874 | 8/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.46 |
| ▸ | RECQL | P46063 | 2/20 | 0.46 |
| ▸ | JAK2 | O60674 | 1/20 | 0.44 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.44 |
| ▸ | MELK | Q14680 | 1/20 | 0.44 |
| ▸ | STK24 | Q9Y6E0 | 1/20 | 0.44 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | DAO | P14920 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | TYMS | P04818 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25429670 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PARP1TDP1RECQLJAK2 | |
| Water SCHEMBL28570725 | 0.98 | ALDH1A1 (0.92) | ALDH1A1PARP1TDP1RECQLJAK2 | |
| SCHEMBL27034083 | 0.98 | ALDH1A1 (1.00) | ALDH1A1PARP1TDP1RECQLJAK2 | |
| SCHEMBL20086 | 0.98 | ALDH1A1 (1.00) | ALDH1A1PARP1TDP1RECQLJAK2 | |
| SCHEMBL29448530 | 0.98 | ALDH1A1 (1.00) | ALDH1A1PARP1TDP1RECQLJAK2 | |
| SCHEMBL1315230 | 0.96 | ALDH1A1 (0.96) | ALDH1A1PARP1TDP1RECQLJAK2 | |
| Potassium SCHEMBL1315293 | 0.96 | ALDH1A1 (0.96) | ALDH1A1PARP1TDP1RECQLJAK2 | |
| Hydrochloric Acid SCHEMBL7117065 | 0.96 | ALDH1A1 (0.96) | ALDH1A1PARP1TDP1RECQLJAK2 | |
| Water SCHEMBL18317911 | 0.96 | ALDH1A1 (0.96) | ALDH1A1PARP1TDP1RECQLJAK2 | |
| SCHEMBL1316616 | 0.96 | ALDH1A1 (0.96) | ALDH1A1PARP1TDP1RECQLJAK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 480 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025081324-A1 | CHEMILUMINESCENCE REACTION DETECTION REAGENT AND DETECTION METHOD FOR CONTENT OF SPERMINE IN SEMINAL PLASMA | 华北理工大学 | 2025-04-24 | — | — | WO | claimed |
| CN-118085031-A | Biological probe based on enzyme peptide self-assembly and application thereof in detection of OTA | 江南大学 | 2024-05-28 | — | — | CN | claimed |
| CN-117903785-A | Preparation method of transition metal-based luminol nano composite self-luminous material and application of transition metal-based luminol nano composite self-luminous material in light driving treatment of tumors | 南京师范大学 | 2024-04-19 | — | — | CN | claimed |
| US-20240075029-A1 | LUMINOL FOR THE PROPHYLAXIS AND THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2024-03-07 | — | — | US | claimed |
| US-20240041763-A1 | APPARATUS AND METHOD FOR PROTECTING NEURONS AND REDUCING INFLAMMATION AND SCARRING | GALEN THERAPEUTICS LLC | 2024-02-08 | — | — | US | claimed |
| EP-4096628-B1 | USE OF 5-AMINO-2,3-DIHYDRO-1,4-PHTHALAZINEDIONE IN THE INHALATORY TREATMENT OF INFLAMMATORY PULMONARY DISEASES | METRIOPHARM AG (CH) | 2024-01-24 | — | — | EP | claimed |
| WO-2023224983-A1 | COMPOSITION FOR THE DETECTION AND PARTIAL DECONTAMINATION OF CHEMICAL THREAT AGENTS ON SKIN SURFACE FOLLOWING DERMAL EXPOSURE | THE UNITED STATES GOVERNMENT, AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 2023-11-23 | — | — | WO | claimed |
| EP-4255391-A1 | LUMINOL FOR THE PROPHYLAXIS AND THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | MetrioPharm AG (CH) | 2023-10-11 | — | — | EP | claimed |
| WO-2023179905-A1 | COMBINATION OF 5-AMINO-2,3-DIHYDRO-1,4-PHTHALAZINEDIONE AND A FUMARIC ACID ESTER | METRIOPHARM AG (CH) | 2023-09-28 | — | — | WO | claimed |
| EP-4248963-A1 | COMBINATION OF 5-AMINO-2,3-DIHYDRO-1,4-PHTALAZINEDIONE AND A FUMARIC ACID ESTER | MetrioPharm AG (CH) | 2023-09-27 | — | — | EP | claimed |
| WO-2010091257-A1 | PHARMACEUTICAL GRADE PHTHALAZINEDIONES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | BACH PHARMA, INC. (US) | 2010-08-12 | — | — | WO | claimed |
| WO-2010082858-A2 | NEW METHOD FOR OBTAINING 5-AMINO-2,3-DIHYDROPHTHALAZINE-1,4-DIONE ALKALI METAL SALTS AND THEIR USE IN MEDICINE | ABIDOPHARMA PL SP. Z.O.O (PL) | 2010-07-22 | — | — | WO | claimed |
| CN-101221170-A | High-efficiency enzyme promoted chemiluminescence substrate system | SHENZHEN HUAYING BIOTECHNOLOGY (CN) | 2008-07-16 | — | — | CN | claimed |
| US-20020198208-A1 | MEDICINAL PREPARATION AND PROCESS FOR MANUFACTURING THEREOF | ABIDOV, MUSA TAZHUDINOVICH (RU) | 2002-12-26 | — | — | US | claimed |
| US-20020192736-A1 | Assay of peroxidase activity | PIERCE CHEMICAL COMPANY | 2002-12-19 | — | — | US | claimed |
| US-6489326-B1 | SODIUM NUCLEINATE, 2-AMINO-1,2,3,4-TETRAHYDROPHTHALAZINE-1,4-DIONE SODIUM SALT DIHYDRATE, USED AS AN IMMUNOMODULATOR, WHICH ALSO HAS ANTIINFLAMMATORY AND ANTIOXIDANT PROPERTIES | Pavlov, Anatoliy Ivanovich (RU) | 2002-12-03 | — | — | US | claimed |
| EP-0898620-B1 | ASSAY OF PEROXIDASE ACTIVITY | PIERCE CHEMICAL CO (US) | 2002-11-06 | — | — | EP | claimed |
| EP-1203587-A1 | A MEDICAMENT AND METHOD FOR THE PRODUCTION THEREOF | Abidov, Musea Tazhudinovich (RU) | 2002-05-08 | — | — | EP | claimed |
| EP-0898620-A1 | ASSAY OF PEROXIDASE ACTIVITY | PIERCE CHEMICAL COMPANY (US) | 1999-03-03 | — | — | EP | claimed |
| WO-1997039142-A1 | ASSAY OF PEROXIDASE ACTIVITY | PIERCE CHEMICAL COMPANY (US) | 1997-10-23 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240041763-A1 | APPARATUS AND METHOD FOR PROTECTING NEURONS AND REDUCING INFLAMMATION AND SCARRING | MPO, MMP8, GPX1 | ALDH1A1 1160/4885PARP1 1961/4885TDP1 403/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.